Can a Man With Herpes Have a Baby?

A man with herpes can absolutely have a baby. Millions of people with genital herpes become parents, and the vast majority of their children are born perfectly healthy. The central concern is not whether conception is possible but how to protect a partner from acquiring the virus during conception and pregnancy, since a new maternal infection poses the greatest risk to a newborn. With antiviral medication, behavioral precautions, and good timing, that risk drops to a level most couples and their doctors consider very manageable.

Does Herpes Affect Sperm or Fertility?

Herpes simplex virus can show up in semen, though it does so less often than you might expect. One study that collected over 250 semen samples from men with genital HSV-2 found viral DNA in only about 3% of them, and most of those samples were collected during an active outbreak rather than between episodes.¹ So when a man is not having symptoms, the chance of HSV being present in his semen on any given day is quite low.

That said, when HSV is present in semen, it can affect sperm quality. A systematic review found that HSV contamination in semen is a possible risk factor for male infertility because it can reduce sperm count, vitality, and motility while increasing DNA fragmentation in sperm cells.² A separate study examining men with asymptomatic seminal HSV found that while the virus did not seem to affect sperm shape or swimming ability, it was linked to lower overall sperm count.³

For most men with herpes, these effects do not prevent conception. The impacts on sperm tend to matter more in men who are already on the borderline of fertility for other reasons. If you have been trying to conceive for a while without success and you have genital herpes, it is worth mentioning to a fertility specialist so they can factor it into their evaluation. But herpes alone is rarely the reason a couple cannot get pregnant.

The Real Risk During Conception Is Transmitting to Your Partner

The practical worry for most couples is not whether his sperm can do the job but whether unprotected sex during the fertile window will give his partner herpes. This matters a great deal, because herpes acquired for the first time during pregnancy carries real risks for the baby, while herpes that a woman already had before pregnancy is far less dangerous.

The numbers on transmission during pregnancy are sobering enough to take seriously but not so high that they should discourage anyone. In a large couples study, roughly 20% of women who were HSV-2 negative but had an HSV-2 positive partner acquired the infection over the course of a pregnancy.⁴ That figure represents the rate without consistent use of antivirals or condoms, and the actual per-act risk is much lower when protective measures are in place. A study of serodiscordant couples found that condom use reduced the per-act risk of male-to-female HSV-2 transmission by about 96%.⁵

Of course, condoms are not ideal when you are trying to conceive. This is where the conversation gets more strategic.

How Antiviral Medication Changes the Math

Daily suppressive antiviral therapy is the single most effective tool for a man with herpes who wants to minimize the chance of passing the virus to his partner. A landmark trial published in the New England Journal of Medicine found that taking valacyclovir daily cut the rate at which the infected partner shed virus from about 11% of days down to roughly 3% of days. Symptomatic HSV-2 infections in the susceptible partners dropped by 75%, and overall acquisition of HSV-2, including cases with no symptoms, fell by about half.⁶

Those results hold up consistently. A separate randomized controlled trial in serodiscordant heterosexual couples confirmed a 48% reduction in HSV-2 transmission with daily suppressive therapy.⁷ The combination of daily antivirals and condom use during non-fertile times, with unprotected sex limited to the narrow fertile window, is the approach many couples and clinicians settle on. Some couples choose to use condoms throughout and rely on assisted methods for conception, but most find the combination strategy sufficient.

Antivirals also reduce the frequency of outbreaks themselves, from roughly one outbreak every two to three months down to roughly one per nine months on daily valacyclovir.⁶ Fewer outbreaks mean fewer periods when you need to avoid sex entirely, which makes timing conception around the fertile window more practical.

Why the Timing of a New Infection Matters So Much

The reason clinicians care so much about protecting the pregnant partner is that a brand-new herpes infection during pregnancy, especially in the second half, carries the highest risk of complications for the baby.⁸ When a woman catches herpes for the first time late in pregnancy, her body has not had time to build antibodies against the virus. That means the virus can be actively present in the genital tract at delivery, and the baby has no borrowed maternal immunity to fight it off.

Neonatal herpes, while rare in absolute terms, can be severe. It can cause skin lesions, eye damage, and neurological problems. In the most serious cases it affects the brain or spreads throughout the body. Intrauterine infection causing congenital abnormalities is possible but quite unusual.⁹ The overwhelming majority of neonatal herpes cases come from contact with the virus in the birth canal during delivery, not from infection that crosses the placenta earlier in pregnancy.

This is the key distinction that drives every clinical recommendation: a first-time maternal infection near delivery is dangerous, while a well-established maternal infection is not. Most neonatal herpes cases are linked to primary maternal infection, which fits with the understanding that existing maternal antibodies are protective. Research has confirmed that mothers who already have HSV antibodies pass those antibodies to their babies through the placenta, providing a layer of defense.¹⁰

What If Your Partner Already Has Herpes Too?

If both you and your partner are HSV-2 positive, the dynamic changes considerably. There is no risk of a new primary infection because she already carries the virus and has built antibodies against it. Those antibodies cross the placenta and help protect the baby. The remaining concern is managing outbreaks around the time of delivery, which is standard obstetric practice. Clinicians typically prescribe suppressive antivirals starting around 36 weeks of pregnancy to minimize the chance of an active outbreak at delivery. If sores are present when labor begins, a cesarean section is recommended to avoid exposing the baby.

The same logic applies if your partner contracted herpes well before the pregnancy. Even if you were the source, once her immune system has had months or years to develop a robust antibody response, the risk to a future baby is low. The concern is concentrated almost entirely on women who acquire the virus for the first time during pregnancy.

The Value of Knowing Your Status Before Trying

One of the strongest things a couple can do is get type-specific herpes blood testing before trying to conceive. Knowing who carries what changes the entire strategy. A study of pregnant couples found that when women knew their partners were HSV-2 positive and they were not, they significantly reduced unprotected sex compared to couples who did not know their status. Women in couples aware of the mismatch reported unprotected genital contact on only about 2% of days, compared to 8-11% in couples who were unaware of the risk.¹¹

Knowledge alone is protective because it changes behavior. Couples who know they are discordant are more likely to use antivirals consistently, more careful about avoiding sex during prodromal symptoms or outbreaks, and more deliberate about limiting unprotected contact to the days most likely to result in conception. It also means the obstetrician can monitor for any signs of new infection and respond quickly if needed.

Assisted Reproduction When the Risk Feels Too High

Some couples prefer to eliminate transmission risk entirely by using assisted reproductive technology. In theory, sperm can be processed to separate it from seminal fluid where the virus resides. In practice, this is not as clean a solution as it sounds. One laboratory study found that density gradient centrifugation, a standard sperm-washing technique used before IVF and other procedures, failed to remove HSV from nearly 60% of infected samples.¹² That finding raised concerns because the virus can attach directly to sperm cells rather than just floating in the surrounding fluid.

This does not mean IVF or intrauterine insemination are off the table. Many fertility clinics still offer these procedures to couples affected by herpes, often with additional testing of the washed sample before use. Screening protocols for semen donors have long recommended type-specific HSV testing precisely because of the possibility of asymptomatic shedding and transmission through donated semen.¹³ If you are pursuing assisted reproduction, discuss the specific protocols your clinic uses to manage herpes risk. The field is aware of the issue even if no method is guaranteed to remove the virus completely.

Practical Strategy for Couples Trying to Conceive

Putting this together, the approach most clinicians recommend looks something like this:

• Daily antivirals: The man with herpes starts daily suppressive therapy (usually valacyclovir) well before the couple begins trying to conceive and continues throughout the pregnancy.
• Fertile-window timing: Unprotected sex is limited to the few days around ovulation each cycle, reducing total exposure while maximizing the chance of conception.
• Outbreak awareness: No sexual contact during active outbreaks or when prodromal symptoms like tingling or burning are present. HSV shedding is closely tied to clinical reactivation.
• Condoms outside the fertile window: When pregnancy is not the immediate goal during a given cycle, barrier protection stays in place.
• Blood testing: Both partners should be tested for HSV-1 and HSV-2 so the couple and their doctor know exactly what they are dealing with.

Guidelines for managing herpes in pregnancy also recommend that clinicians counsel couples about these strategies early, ideally before conception.¹⁴ The conversation is much less stressful when it happens during planning than when a woman is already pregnant and discovers her partner has herpes.

What Happens at Delivery

Even if the mother does acquire herpes during pregnancy, it does not automatically mean the baby will be harmed. When a new infection occurs early in pregnancy, the mother usually develops enough antibodies by the time of delivery to protect the newborn. The dangerous scenario is acquisition in the final weeks, when there is not enough time for a full immune response.

If a woman has active genital lesions at the time of labor, a cesarean delivery is the standard recommendation to prevent the baby from coming into contact with the virus in the birth canal. For women with a history of genital herpes but no active lesions, vaginal delivery is considered safe. Suppressive antiviral therapy in the final weeks of pregnancy further reduces the chance of an outbreak at delivery.

The overall risk of neonatal herpes in the general population is estimated at roughly 1 in 3,000 to 1 in 20,000 deliveries depending on the country and population studied. For couples who know their status and follow the precautions described above, the risk is at the lower end of that range or below it.

Gene Editing and the Future of Herpes Treatment

For men living with herpes who are thinking about future family planning, emerging research offers a reason for cautious optimism beyond current antivirals. Scientists have been exploring gene-editing approaches that target the latent herpes virus hiding in nerve cells, which is the reservoir that causes lifelong infection and periodic reactivation. A 2024 study using an engineered meganuclease delivered by gene therapy vectors achieved a 79% to 96% reduction in latent viral genomes in the nerve tissue of genitally infected animals.¹⁵ Treated animals also appeared to shed less virus, though the study’s reactivation rates were low enough that the difference was hard to measure with statistical precision.

This research is still in animal models and years from clinical use. But it represents a fundamentally different approach from antivirals, which suppress the virus without eliminating it. If gene editing can reduce or destroy the latent reservoir, it could eventually mean far less shedding, fewer outbreaks, and a much lower transmission risk during conception. For now, the combination of daily suppressive therapy, condoms, and strategic timing remains the standard of care, and it works well enough that herpes is rarely a barrier to becoming a parent.